FDA recall D-0151-2017

Mylan Pharmaceuticals Inc. · Class III · drug

Product

Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC 0378-5220-05), Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA

Reason for recall

Failed Impurities/Degradation Specifications: OOS results for known compound.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2016-11-03
Report date
2016-11-30
Termination date
2017-08-01
Voluntary/Mandated
Voluntary: Firm initiated
Location
Morgantown, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0151-2017